Functional Brands closes $8 million private placement and completes Nasdaq listing
Director Richelle P. Parham of Labcorp Holdings Inc (NYSE:LH) sold 7,009 shares of common stock on October 31, 2025, for $254.2835, totaling approximately $1.78 million. Following the transaction, Parham directly owns 2,469 shares of Labcorp.This insider sale comes as Labcorp trades near $254 with a market cap of $21 billion. The healthcare services provider boasts a perfect Piotroski Score of 9, indicating exceptional financial strength, while trading at a P/E of 25 with a remarkably low PEG ratio of 0.25. InvestingPro analysis suggests the stock is slightly overvalued compared to its Fair Value, despite management’s aggressive share buyback program and the company’s 1.12% dividend yield. Investors seeking deeper insights can access the comprehensive Pro Research Report, available for Labcorp and 1,400+ other US equities on InvestingPro.
In other recent news, LabCorp has reported strong financial results for the third quarter of 2025. The company achieved an adjusted earnings per share (EPS) of $4.18, slightly surpassing the anticipated $4.13, which translates to a positive surprise of 1.21%. Revenue for the quarter reached $3.6 billion, in line with forecasts. Despite these positive earnings and revenue figures, the stock saw a decline in pre-market trading, possibly due to broader market concerns. Additionally, Leerink Partners has reiterated its Outperform rating on LabCorp stock, maintaining a price target of $342.00. The firm views the recent dip in stock price as a buying opportunity, describing LabCorp as a "durable compounder" with strong growth drivers. These developments highlight the company’s current market position and potential future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.